Baseline data collected from OSR medical recordsa | Collected through standard of care procedures performed by the patient’s local HCP (e.g. referring paediatric immunologist) For patients treated in the clinical studies, baseline and follow-up data will be obtained retrospectively from records at OSR or trial database | |||||
---|---|---|---|---|---|---|
Observational data and minimal time points for their collection | Pre-treatment phasef | Treatment phase (Year 0)f | Annually Years 1 to 11 | Year 13 | Year 15 | >Year 15 |
General | ||||||
 Medical history | ✓ | |||||
 Demographics | ✓ | |||||
 Gene therapy date / dose / lot no. | ✓ | |||||
 Growth (height and weight) | ✓ | ✓ | ✓ | ✓ | ||
 Survival | ✓ | ✓ | ✓ | ✓g | ||
 Fertility and pregnancy outcomes | ✓ | ✓ | ✓ | ✓g | ||
 Oncogenesis | ✓ | ✓ | ✓ | ✓g | ||
 Development and QoL | ✓ | ✓ | ✓ | ✓ | ||
Use of medication/treatments of interest | ||||||
 ERT, HSCT, radiotherapy, cytotoxic agents | ✓ | ✓ | ✓ | |||
AEs | ||||||
 Reported SAEs | ✓ | ✓ | ✓ | ✓ | ✓ | |
 Reported AEs | ✓ | ✓ | ✓ | ✓ | ✓ | |
 AEs of interesta | ✓ | ✓ | ✓ | ✓ | ✓ | |
Specialist lab assessmentsb | ||||||
 dAxP RBCs | ✓ | ✓ | ✓ | ✓ | ✓ | |
 Busulfan AUC | ✓ | |||||
 Immunogenicityc | ✓ | ✓ | ✓ | ✓ | ||
 Vector copy numberd | ✓ | ✓ | ✓ | ✓ | ||
 T-cell function | ✓ | ✓ | ✓ | ✓ | ✓ | |
 RIS and RCRe | ✓ | ✓ | ✓ | |||
General lab assessmentsb | ||||||
 Peripheral lymphocyte counts | ✓ | ✓ | ✓ | ✓ | ✓ | |
 Laboratory blood test results | ✓ | ✓ | ✓ | ✓ | ✓ |